We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
-1.67%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$100B
AUM Growth
-$8.74B
Cap. Flow
-$1.7B
Cap. Flow %
-1.7%
Top 10 Hldgs %
9.77%
Holding
2,893
New
146
Increased
1,494
Reduced
995
Closed
170

Sector Composition

Rank Sector Weight
1 Technology 16.9%
2 Industrials 13.89%
3 Financials 12.91%
4 Consumer Discretionary 10.69%
5 Healthcare 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEI
2676
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$5K ﹤0.01%
681
-35
-5% -$467
ABEO icon
2677
Abeona Therapeutics
ABEO
$415M
$4K ﹤0.01%
730
-62
-8% -$426
DOMH icon
2678
Dominari Holdings
DOMH
$62.4M
$4K ﹤0.01%
701
-20
-3% -$159
RMTI icon
2679
Rockwell Medical
RMTI
$27M
$4K ﹤0.01%
112
+4
+4% +$169
NXTP
2680
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$4K ﹤0.01%
508
+1
+0.2% +$13
SRGA
2681
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$4K ﹤0.01%
777
+203
+35% +$3.08K
EVFM
2682
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$4K ﹤0.01%
1,625
+138
+9% +$868
SLNO
2683
DELISTED
Soleno Therapeutics
SLNO
$3K ﹤0.01%
+892
New +$4.62K
FRTX
2684
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$3K ﹤0.01%
344
-6
-2% -$65
CWBR
2685
DELISTED
CohBar, Inc. Common Stock
CWBR
$3K ﹤0.01%
357
+15
+4% +$142
REED
2686
DELISTED
Reeds, Inc. Common Stock
REED
$3K ﹤0.01%
283
+46
+19% +$711
CALA
2687
DELISTED
Calithera Biosciences, Inc
CALA
$3K ﹤0.01%
+583
New +$5.96K
ALNA
2688
DELISTED
Allena Pharmaceuticals
ALNA
$2K ﹤0.01%
10,745
-306
-3% -$127
PTE
2689
DELISTED
PolarityTE, Inc. Common Stock
PTE
$2K ﹤0.01%
466
+32
+7% +$370
ACRS icon
2690
Aclaris Therapeutics
ACRS
$866M
-22,650
Closed -$329K
AGIO icon
2691
Agios Pharmaceuticals
AGIO
$1.93B
-12,227
Closed -$402K
AMPL icon
2692
Amplitude
AMPL
$1.52B
-5,067
Closed -$268K
APPF icon
2693
AppFolio
APPF
$7.06B
-1,917
Closed -$232K
OPTU
2694
Optimum Communications Inc
OPTU
$308M
-120,551
Closed -$1.95M
BALY icon
2695
Bally's
BALY
$636M
-7,939
Closed -$302K
BAND
2696
Bandwidth Inc
BAND
$1.71B
-1,065,222
Closed -$76.4M
BGFV
2697
DELISTED
Big 5 Sporting Goods
BGFV
-100,772
Closed -$1.92M
BOOM icon
2698
DMC Global
BOOM
$155M
-6,865
Closed -$272K
BW icon
2699
Babcock & Wilcox
BW
$1.36B
-30,427
Closed -$274K
CASS icon
2700
Cass Information Systems
CASS
$735M
-198,712
Closed -$7.81M

Similar funds

Victory Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Victory Capital Management held 2,893 positions worth $100B, down 8% from $109B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Victory Capital Management's Q1 2022 filing shows 146 new, 1,494 increased, 995 reduced and 170 closed positions. Its largest new stake was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.49B.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Victory Capital Management's largest Q1 2022 buy was Intra-Cellular Therapies Inc.: 932,322 shares worth $56.9M.
  • Victory Capital Management added most to MKS Inc in Q1 2022, an estimated $219M increase.
  • Victory Capital Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.49B.
  • Victory Capital Management fully exited Vanguard Total World Stock ETF in Q1 2022, selling an estimated $476M.
  • Victory Capital Management's ten largest holdings make up 9.8% of its $100B portfolio in Q1 2022.
  • Victory Capital Management opened 146 new positions and closed 170 in Q1 2022.
  • Victory Capital Management's portfolio value fell 8% quarter-over-quarter to $100B.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.